👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

Midday movers: UBS, Kellanova rise; Starbucks slips

Published 14/08/2024, 12:34
© Reuters
INTC
-
GOOGL
-
SBUX
-
MDT
-
CAH
-
K
-
CMG
-
TCEHY
-
UBSG
-
PTON
-
(Updated - August 14, 2024 11:37 AM EDT)

Investing.com -- U.S. stock futures rose Wednesday following the release of the latest consumer prices data that showed inflation eased in-line with expectations.

Here are some of the biggest U.S. stock movers today:

  • Intel (NASDAQ:INTC) stock fell 2% after a regulatory filing showed the chipmaker sold its 1.18 million share stake in Arm Holdings (ARM), up 2.8%, in the second quarter, after saying earlier this month that it would cut more than 15% of its workforce and suspend its dividend amid a pullback in spending.

  • Kellanova (K) stock rose 8% after it entered into a definitive agreement under which Mars has agreed to acquire Kellanova for $83.50 per share in cash.

  • Peloton (NASDAQ:PTON) stock fell 3.5% after the exercise equipment maker announced a partnership with Google's (NASDAQ:GOOGL) Fitbit (NYSE:FIT) to give its premium users access to its fitness content, starting early September.

  • Starbucks (NASDAQ:SBUX) stock fell 4%, handing back some of the previous session’s hefty gains after the coffee chain named Chipotle's (NYSE:CMG)'s Brian Niccol as its new CEO, replacing Laxman Narasimhan, who was at the helm for close to a year and a half.

  • UBS (UBS) stock rose 5% after the Swiss banking giant reported an impressive second-quarter performance, detailing a net profit of $1.14 billion, comfortably surpassing forecasts.

  • Cardinal Health (NYSE:CAH) (CAH) stock rose 5.5% after the health care services company raised its 2025 fiscal year guidance after strong 2024 results.

  • Tencent Holdings (HK:0700) (OTC:TCEHY) stock was in focus after the world's largest video game company and operator of the WeChat messaging platform reported an 8% rise in second-quarter revenue, driven by a recovery in its gaming business.

  • Medtronic (NYSE:MDT) (MDT) stock fell 1.6% after analysts downgraded its stance on the medical device company to ‘hold’ from buy’, citing a difficult growth outlook.


Additional reporting by Louis Juricic

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.